Author:
Sharma Priyanka,Nandave Mukesh,Kumar Anoop
Publisher
Springer Nature Singapore
Reference29 articles.
1. Ahmad A, Patel I, Balkrishnan R, Mohanta GP, Manna PK (2013) An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: a pilot study. Perspect Clin Res 4:204–210. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835963/. Accessed 18 Jul 2023
2. Blake KV, Zaccaria C, Domergue F, La Mache E, Saint-Raymond A, Hidalgo-Simon A (2014) Comparison between paediatric and adult suspected adverse drug reactions reported to the European Medicines Agency: implications for pharmacovigilance. Pediatr Drugs 16(4):309–319. https://doi.org/10.1007/S40272-014-0076-2
3. Brucker MC, King TL (2017) The 2015 US Food and Drug Administration pregnancy and lactation labeling rule. J Midwifery Womens Health 62(3):308–316. https://doi.org/10.1111/JMWH.12611
4. Chatterjee S, Lyle N, Ghosh S (2006) A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India. Drug Saf 29(7):641–642. https://doi.org/10.2165/00002018-200629070-00009
5. Collaboration and Information Sharing Among India, US and EU—Google Scholar (n.d.). Available from https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Collaboration+and+Information+Sharing+Among+India%2C+US+and+EU&btnG=. Accessed 18 July 2023